Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

HQ
540-1385 West 8th Avenue
British Columbia,
Vancouver, V6H 3V9, CAN

People

Chairman, Board of Director
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
President, CEO, Board of Director
Vice President, Preclinical Research and Development
Board of Director
Board of Director
Show All People

Funding

TOTAL $38.9M
FUNDING TOTAL $38.9M
Angel, 3/2008
$1.3M
Series C, 6/2009
CTI Capital
$3.5M
Series D, 9/2011
CTI Capital
$8.1M
Venture Round, 9/2012
$11M
Venture Round, 1/2014
$15M

Tags

Zymeworks

Zymeworks Inc. is a privately held computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

Recent Milestones

Videos

Screenshots

Zymeworks screenshot
Above: Zymeworks Screenshot -- #1
Uploaded: 6/26/09

Sources

  1. Zymeworks Announces Closing of Financing and Addition to Board of Directors (zymeworks.com) [edit]
  2. Zymeworks, Inc.: Series C $3.5M (onbiovc.com) [edit]
  3. Zymeworks Raises $8.1M (finsmes.com) [edit]
  4. Zymeworks Raises $11.0M in Funding (finsmes.com) [edit]
  5. Zymeworks Nabs $15M, Adds Lilly Partnership, in Antibody Drug Quest (xconomy.com) [edit]
Edit This Page
Last Edited 3/28/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy